NEWS DETAIL

FDA approves gedatolisib with fulvestrant, with or without palbociclib, for HR-positive, HER2-negative locally advanced or metastatic breast cancer

On July 14,2026, the Food and Drug Administration approved gedatolisib (Revtorpyk, Celcuity Inc.

July 15, 2026

该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。

Produtos relacionados com este artigo

Estes produtos foram associados automaticamente a partir do titulo, resumo e conteudo do artigo.

Perguntas frequentes

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Pabocicni – Palbociclib – Compre online.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.